Category Archives: Recent News

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
May 19, 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, May 19, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell to Participate at Upcoming Conferences and Appoints Senior R&D Director
May 11, 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, May 11, 2021— BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) ...

BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com
April 21, 2021

AUSTIN, Texas, April 21, 2021 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of ...

BriaCell Announces Investor and Media Outreach Programs
April 15, 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, April 15, 2021— BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) ...

BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million
April 12, 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, April 12, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021
April 12, 2021

Clinical and pathological data presented from the clinical trials of Bria-IMT™ alone and in combination ...

BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021
March 30, 2021

• Clinical and pathological findings from clinical trial of the Bria-IMT™ regimen alone and in ...

BriaCell Announces Closing of US$25 Million Public Offering
February 26, 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, February 26, 2021— BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, ...

BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing
February 23, 2021

BERKELEY, Calif. and VANCOUVER, British Columbia, February 23, 2021— BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, ...

BriaCell Presents Clinical Data at 2021 Keystone Symposium
January 26, 2021

Clinical and pathological findings presented from the clinical trials of Bria-IMT™ alone or in combination ...

Skip to content